Air Quality Sciences Offers New Method for Detecting Toxic Mold

Article

ATLANTA -- Atlanta-based indoor air quality company Air Quality Sciences, Inc. (AQS), now offers a new analysis to test for Stachybotrys chartarum, often referred to as toxic mold, in a fungal sample. AQS is now proposing the use of Stachybotrys Selective Agar (SSA) to better detect the presence of this toxic mold in samples taken by building investigators.

SSA is specifically formulated to selectively recover Stachybotrys chartarum, using a combination of anti-fungal and antibiotic agents to prevent other fungi and bacteria from inhibiting the growth of Stachybotrys in the sample. Stachybotrys Selective Agar is designed to be used in combination with existing full characterization media such as MEA and DG-18, providing a complete picture of all fungi present in a sample. The addition of SSA to Air Quality Sciences' already extensive analytical capabilities enables building investigators to efficiently determine what mold species exist in a building.

SSA is ideal for experienced building investigators whose cases require full fungal species identification, such as high profile cases that may involve health concerns or litigation. The new agar is used in combination with existing laboratory agars to properly detect the presence of Stachybotrys chartarum, resulting in a comprehensive report for building investigators.

Stachybotrys Selective Agar can be used in conjunction with other agars to provide a building investigator with more complete information regarding the viable fungi of interest in a given environment. At AQS, all samples are expertly analyzed exclusively by degreed analysts and in accordance with AIHA EMLAP specifications.

Source: Air Quality Sciences, Inc.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.